Skip to main content
Erschienen in: Surgical Endoscopy 1/2020

16.04.2019

Long-term outcomes of superficial neoplasia at the esophagogastric junction treated via endoscopic submucosal dissection and endoscopic submucosal tunnel dissection: a cohort study of a single center from China

verfasst von: Shengzhen Liu, Ningli Chai, Zhongsheng Lu, Huikai Li, Ying Xiong, Yaqi Zhai, Enqiang Linghu

Erschienen in: Surgical Endoscopy | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background and aims

The techniques and indications for endoscopic submucosal dissection (ESD) and endoscopic submucosal tunnel dissection (ESTD) to remove superficial neoplasia at the esophagogastric junction (EGJ) have been developed and expanded. However, the resection of superficial neoplasia at the EGJ by ESD remains challenging, and the long-term clinical outcomes of curative and non-curative resections based on histological criteria remain unclear. We conducted a retrospective analysis on the safety and efficacy of the ESD and ESTD procedure with these patients.

Methods

The records of 209 consecutive patients at the Chinese PLA General Hospital who received ESD and ESTD to treat EGJ superficial neoplasia from November 2006 to December 2016 were reviewed for this retrospective cohort study. We divided patients into two groups (curative and non-curative resection).

Results

Of all 14 additional surgeries, 1 patient in the curative group and 13 in the non-curative group underwent surgical operation with residual tumor in 7 specimens. During a median follow-up period of 46.4 months (range 12.2–142.3 months), the 5-year survival rate was 98.6%. Two patients died 91 months and 66 months after surgery due to subarachnoid hemorrhage and lymphoma, respectively. One patient died of gastric cancer 1 year after the surgery. The 5-year disease-specific survival rate was 99.5%. Local tumor recurrence was detected in 9 of 209 cases.

Conclusions

In conclusion, ESD was shown to be a safe and effective treatment strategy for early EGJ neoplasia. Mucosal adhesion may increase the difficulty of piecemeal curative resection, but the superficial depth of such an invasion favors better clinical outcomes. Additional surgical resection is a good choice for non-curative ESD, and re-ESD is also an alternative, in conjunction with intensive follow-up.
Literatur
1.
Zurück zum Zitat Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–132CrossRef Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–132CrossRef
2.
Zurück zum Zitat Buas MF, Vaughan TL (2013) Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol 23:3–9CrossRef Buas MF, Vaughan TL (2013) Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol 23:3–9CrossRef
3.
Zurück zum Zitat Zhang XD, Shu YQ, Liang J, Zhang FC, Ma XZ, Huang JJ et al (2012) Combination chemotherapy with paclitaxel, cisplatin and fluorouracil for patients with advanced and metastatic gastric or esophagogastric junction adenocarcinoma: a multicenter prospective study. Chin J Cancer Res 24:291–298CrossRef Zhang XD, Shu YQ, Liang J, Zhang FC, Ma XZ, Huang JJ et al (2012) Combination chemotherapy with paclitaxel, cisplatin and fluorouracil for patients with advanced and metastatic gastric or esophagogastric junction adenocarcinoma: a multicenter prospective study. Chin J Cancer Res 24:291–298CrossRef
4.
Zurück zum Zitat Hirao M, Masuda K, Asanuma T, Naka H, Noda K, Matsuura K et al (1988) Endoscopic resection of early gastric cancer and other tumors with local injection of hypertonic saline-epinephrine. Gastrointest Endosc 34:264–269CrossRef Hirao M, Masuda K, Asanuma T, Naka H, Noda K, Matsuura K et al (1988) Endoscopic resection of early gastric cancer and other tumors with local injection of hypertonic saline-epinephrine. Gastrointest Endosc 34:264–269CrossRef
5.
Zurück zum Zitat Ohkuwa M, Hosokawa K, Boku N, Ohtu A, Tajiri H, Yoshida S (2001) New endoscopic treatment for intramucosal gastric tumors using an insulated-tip diathermic knife. Endoscopy 33:221–226CrossRef Ohkuwa M, Hosokawa K, Boku N, Ohtu A, Tajiri H, Yoshida S (2001) New endoscopic treatment for intramucosal gastric tumors using an insulated-tip diathermic knife. Endoscopy 33:221–226CrossRef
6.
Zurück zum Zitat Gong EJ, Kim DH, Ahn JY, Jung KW, Lee JH, Choi KD et al (2017) Comparison of long-term outcomes of endoscopic submucosal dissection and surgery for esophagogastric junction adenocarcinoma. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc 20:84–91 Gong EJ, Kim DH, Ahn JY, Jung KW, Lee JH, Choi KD et al (2017) Comparison of long-term outcomes of endoscopic submucosal dissection and surgery for esophagogastric junction adenocarcinoma. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc 20:84–91
7.
Zurück zum Zitat Yamada M, Oda I, Nonaka S, Suzuki H, Yoshinaga S, Taniguchi H et al (2013) Long-term outcome of endoscopic resection of superficial adenocarcinoma of the esophagogastric junction. Endoscopy 45:992–996CrossRef Yamada M, Oda I, Nonaka S, Suzuki H, Yoshinaga S, Taniguchi H et al (2013) Long-term outcome of endoscopic resection of superficial adenocarcinoma of the esophagogastric junction. Endoscopy 45:992–996CrossRef
8.
Zurück zum Zitat Park CH, Kim EH, Kim HY, Roh YH, Lee YC (2015) Clinical outcomes of endoscopic submucosal dissection for early stage esophagogastric junction cancer: a systematic review and meta-analysis. Dig Liver Dis 47:37–44CrossRef Park CH, Kim EH, Kim HY, Roh YH, Lee YC (2015) Clinical outcomes of endoscopic submucosal dissection for early stage esophagogastric junction cancer: a systematic review and meta-analysis. Dig Liver Dis 47:37–44CrossRef
9.
Zurück zum Zitat Pech O, Bollschweiler E, Manner H, Leers J, Ell C, Holscher AH (2011) Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg 254:67–72CrossRef Pech O, Bollschweiler E, Manner H, Leers J, Ell C, Holscher AH (2011) Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg 254:67–72CrossRef
10.
Zurück zum Zitat Das A, Singh V, Fleischer DE, Sharma VK (2008) A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol 103:1340–1345CrossRef Das A, Singh V, Fleischer DE, Sharma VK (2008) A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol 103:1340–1345CrossRef
11.
Zurück zum Zitat Ono H, Yao K, Fujishiro M, Oda I, Nimura S, Yahagi N et al (2016) Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Digestive Endosc Off J Jpn Gastroenterol Endosc Soc 28:3–15 Ono H, Yao K, Fujishiro M, Oda I, Nimura S, Yahagi N et al (2016) Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Digestive Endosc Off J Jpn Gastroenterol Endosc Soc 28:3–15
12.
Zurück zum Zitat Japanese classification of gastric carcinoma: 3rd English edition (2011). Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc 14:101–112 Japanese classification of gastric carcinoma: 3rd English edition (2011). Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc 14:101–112
13.
Zurück zum Zitat Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457–1459CrossRef Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457–1459CrossRef
14.
Zurück zum Zitat The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002 (2003). Gastrointest Endosc 58:S3–S43 The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002 (2003). Gastrointest Endosc 58:S3–S43
15.
Zurück zum Zitat Wen J, Linghu E, Yang Y, Liu Q, Yang J, Wang S et al (2014) Effectiveness and safety of endoscopic submucosal dissection for intraepithelial neoplasia of the esophagogastric junction. Chin Med J 127:417–422PubMed Wen J, Linghu E, Yang Y, Liu Q, Yang J, Wang S et al (2014) Effectiveness and safety of endoscopic submucosal dissection for intraepithelial neoplasia of the esophagogastric junction. Chin Med J 127:417–422PubMed
16.
Zurück zum Zitat Linghu E, Feng X, Wang X, Meng J, Du H, Wang H (2013) Endoscopic submucosal tunnel dissection for large esophageal neoplastic lesions. Endoscopy 45:60–62PubMed Linghu E, Feng X, Wang X, Meng J, Du H, Wang H (2013) Endoscopic submucosal tunnel dissection for large esophageal neoplastic lesions. Endoscopy 45:60–62PubMed
17.
Zurück zum Zitat Imai K, Kakushima N, Tanaka M, Takizawa K, Matsubayashi H, Hotta K et al (2013) Validation of the application of the Japanese curative criteria for superficial adenocarcinoma at the esophagogastric junction treated by endoscopic submucosal dissection: a long-term analysis. Surg Endosc 27:2436–2445CrossRef Imai K, Kakushima N, Tanaka M, Takizawa K, Matsubayashi H, Hotta K et al (2013) Validation of the application of the Japanese curative criteria for superficial adenocarcinoma at the esophagogastric junction treated by endoscopic submucosal dissection: a long-term analysis. Surg Endosc 27:2436–2445CrossRef
18.
Zurück zum Zitat Yoshinaga S, Gotoda T, Kusano C, Oda I, Nakamura K, Takayanagi R (2008) Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction. Gastrointest Endosc 67:202–209CrossRef Yoshinaga S, Gotoda T, Kusano C, Oda I, Nakamura K, Takayanagi R (2008) Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction. Gastrointest Endosc 67:202–209CrossRef
19.
Zurück zum Zitat Wang SJ, Wu ML, Zhang LW, Guo XQ, Xu ZB, Er LM et al (2008) The value of endoscopic mucosal resection for dysplasia and early-stage cancer of the esophagus and gastric cardia. Zhonghua Zhong Liu Za Zhi 30:853–857PubMed Wang SJ, Wu ML, Zhang LW, Guo XQ, Xu ZB, Er LM et al (2008) The value of endoscopic mucosal resection for dysplasia and early-stage cancer of the esophagus and gastric cardia. Zhonghua Zhong Liu Za Zhi 30:853–857PubMed
20.
Zurück zum Zitat Jeon MY, Park JC, Hahn KY, Shin SK, Lee SK, Lee YC. Long-term outcomes after noncurative endoscopic resection of early gastric cancer: the optimal time for additional endoscopic treatment. Gastrointest Endosc. 2017 Jeon MY, Park JC, Hahn KY, Shin SK, Lee SK, Lee YC. Long-term outcomes after noncurative endoscopic resection of early gastric cancer: the optimal time for additional endoscopic treatment. Gastrointest Endosc. 2017
21.
Zurück zum Zitat Suzuki H, Oda I, Abe S, Sekiguchi M, Nonaka S, Yoshinaga S et al (2017) Clinical outcomes of early gastric cancer patients after noncurative endoscopic submucosal dissection in a large consecutive patient series. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc 20:679–689 Suzuki H, Oda I, Abe S, Sekiguchi M, Nonaka S, Yoshinaga S et al (2017) Clinical outcomes of early gastric cancer patients after noncurative endoscopic submucosal dissection in a large consecutive patient series. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc 20:679–689
22.
Zurück zum Zitat Japanese gastric cancer treatment guidelines 2014 (ver.) 4 (2017). Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc 20:1–19 Japanese gastric cancer treatment guidelines 2014 (ver.) 4 (2017). Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc 20:1–19
23.
Zurück zum Zitat Ono H (2006) Early gastric cancer: diagnosis, pathology, treatment techniques and treatment outcomes. Eur J Gastroenterol Hepatol 18:863–866CrossRef Ono H (2006) Early gastric cancer: diagnosis, pathology, treatment techniques and treatment outcomes. Eur J Gastroenterol Hepatol 18:863–866CrossRef
24.
Zurück zum Zitat Omae M, Fujisaki J, Horiuchi Y, Yoshizawa N, Matsuo Y, Kubota M et al (2013) Safety, efficacy, and long-term outcomes for endoscopic submucosal dissection of early esophagogastric junction cancer. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc 16:147–154 Omae M, Fujisaki J, Horiuchi Y, Yoshizawa N, Matsuo Y, Kubota M et al (2013) Safety, efficacy, and long-term outcomes for endoscopic submucosal dissection of early esophagogastric junction cancer. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc 16:147–154
25.
Zurück zum Zitat Matsuda T, Kurokawa Y, Yoshikawa T, Kishi K, Misawa K, Ohi M et al (2016) Clinicopathological characteristics and prognostic factors of patients with Siewert Type II esophagogastric junction carcinoma: a retrospective multicenter study. World J Surg 40:1672–1679CrossRef Matsuda T, Kurokawa Y, Yoshikawa T, Kishi K, Misawa K, Ohi M et al (2016) Clinicopathological characteristics and prognostic factors of patients with Siewert Type II esophagogastric junction carcinoma: a retrospective multicenter study. World J Surg 40:1672–1679CrossRef
26.
Zurück zum Zitat Hirasawa K, Kokawa A, Oka H, Yahara S, Sasaki T, Nozawa A et al (2010) Superficial adenocarcinoma of the esophagogastric junction: long-term results of endoscopic submucosal dissection. Gastrointest Endosc 72:960–966CrossRef Hirasawa K, Kokawa A, Oka H, Yahara S, Sasaki T, Nozawa A et al (2010) Superficial adenocarcinoma of the esophagogastric junction: long-term results of endoscopic submucosal dissection. Gastrointest Endosc 72:960–966CrossRef
27.
Zurück zum Zitat Hoteya S, Matsui A, Iizuka T, Kikuchi D, Yamada A, Yamashita S et al (2013) Comparison of the clinicopathological characteristics and results of endoscopic submucosal dissection for esophagogastric junction and non-junctional cancers. Digestion 87:29–33CrossRef Hoteya S, Matsui A, Iizuka T, Kikuchi D, Yamada A, Yamashita S et al (2013) Comparison of the clinicopathological characteristics and results of endoscopic submucosal dissection for esophagogastric junction and non-junctional cancers. Digestion 87:29–33CrossRef
28.
Zurück zum Zitat Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, Repici A, Vieth M, De Ceglie A et al (2015) Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 47:829–854CrossRef Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, Repici A, Vieth M, De Ceglie A et al (2015) Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 47:829–854CrossRef
Metadaten
Titel
Long-term outcomes of superficial neoplasia at the esophagogastric junction treated via endoscopic submucosal dissection and endoscopic submucosal tunnel dissection: a cohort study of a single center from China
verfasst von
Shengzhen Liu
Ningli Chai
Zhongsheng Lu
Huikai Li
Ying Xiong
Yaqi Zhai
Enqiang Linghu
Publikationsdatum
16.04.2019
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 1/2020
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-019-06753-7

Weitere Artikel der Ausgabe 1/2020

Surgical Endoscopy 1/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.